Literature DB >> 26073982

Cross-Presentation in Mouse and Human Dendritic Cells.

Elodie Segura1, Sebastian Amigorena2.   

Abstract

Cross-presentation designates the presentation of exogenous antigens on major histocompatibility complex class I molecules and is essential for the initiation of cytotoxic immune responses. It is now well established that dendritic cells (DCs) are the best cross-presenting cells. In this chapter, we will discuss recent advances in our understanding of the molecular mechanisms of cross-presentation. We will also describe the different DC subsets identified in mouse and human, and their functional specialization for cross-presentation. Finally, we will summarize the current knowledge of the role of cross-presentation in pathological situations.
© 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cross-presentation; DC subsets; Dendritic cells; Human; Phagosome

Mesh:

Substances:

Year:  2015        PMID: 26073982     DOI: 10.1016/bs.ai.2015.03.002

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


  50 in total

Review 1.  Dendritic cells in cancer: the role revisited.

Authors:  Filippo Veglia; Dmitry I Gabrilovich
Journal:  Curr Opin Immunol       Date:  2017-02-10       Impact factor: 7.486

Review 2.  Monocyte differentiation and antigen-presenting functions.

Authors:  Claudia V Jakubzick; Gwendalyn J Randolph; Peter M Henson
Journal:  Nat Rev Immunol       Date:  2017-04-24       Impact factor: 53.106

3.  MARCH9-mediated ubiquitination regulates MHC I export from the TGN.

Authors:  Francesca De Angelis Rigotti; Aude De Gassart; Carina Pforr; Florencia Cano; Prudence N'Guessan; Alexis Combes; Voahirana Camossetto; Paul J Lehner; Philippe Pierre; Evelina Gatti
Journal:  Immunol Cell Biol       Date:  2017-05-31       Impact factor: 5.126

4.  A dendritic cell multitasks to tackle cancer.

Authors:  Marianne Burbage; Sebastian Amigorena
Journal:  Nature       Date:  2020-08       Impact factor: 49.962

5.  Constitutive resistance to viral infection in human CD141+ dendritic cells.

Authors:  Aymeric Silvin; Chun I Yu; Xavier Lahaye; Francesco Imperatore; Jean-Baptiste Brault; Sylvain Cardinaud; Christian Becker; Wing-Hong Kwan; Cécile Conrad; Mathieu Maurin; Christel Goudot; Santy Marques-Ladeira; Yuanyuan Wang; Virginia Pascual; Esperanza Anguiano; Randy A Albrecht; Matteo Iannacone; Adolfo García-Sastre; Bruno Goud; Marc Dalod; Arnaud Moris; Miriam Merad; A Karolina Palucka; Nicolas Manel
Journal:  Sci Immunol       Date:  2017-07-07

Review 6.  Dendritic Cells and Cancer Immunity.

Authors:  Alycia Gardner; Brian Ruffell
Journal:  Trends Immunol       Date:  2016-10-25       Impact factor: 16.687

Review 7.  The origin of DCs and capacity for immunologic tolerance in central and peripheral tissues.

Authors:  K Sanjana P Devi; Niroshana Anandasabapathy
Journal:  Semin Immunopathol       Date:  2016-11-25       Impact factor: 9.623

8.  Approach for Identifying Human Leukocyte Antigen (HLA)-DR Bound Peptides from Scarce Clinical Samples.

Authors:  Tina Heyder; Maxie Kohler; Nataliya K Tarasova; Sabrina Haag; Dorothea Rutishauser; Natalia V Rivera; Charlotta Sandin; Sohel Mia; Vivianne Malmström; Åsa M Wheelock; Jan Wahlström; Rikard Holmdahl; Anders Eklund; Roman A Zubarev; Johan Grunewald; A Jimmy Ytterberg
Journal:  Mol Cell Proteomics       Date:  2016-07-24       Impact factor: 5.911

9.  Reviving up dendritic cells can run cancer immune wheel in non-small cell lung cancer: a prospective two-arm study.

Authors:  Asmaa M Zahran; Helal F Hetta; Shimaa Mansour; Ereny S Saad; Amal Rayan
Journal:  Cancer Immunol Immunother       Date:  2020-09-12       Impact factor: 6.968

10.  Efficient antigen cross-presentation through coating conventional aluminum adjuvant particles with PEI.

Authors:  Hongyan Ren; Yongbin Mou; Lin Lin; Lixin Wang; Hongming Hu
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.